학술논문
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
Document Type
Article
Author
Sun, Jong-Mu ; Shen, Lin; Shah, Manish A; Enzinger, Peter; Adenis, Antoine; Doi, Toshihiko; Kojima, Takashi; Metges, Jean-Philippe; Li, Zhigang; Kim, Sung-Bae; Cho, Byoung Chul; Mansoor, Wasat; Li, Shau-Hsuan; Sunpaweravong, Patrapim; Maqueda, Maria Alsina; Goekkurt, Eray; Hara, Hiroki; Antunes, Luis; Fountzilas, Christos; Tsuji, Akihito; Oliden, Victor Castro; Liu, Qi; Shah, Sukrut; Bhagia, Pooja; Kato, Ken
Source
In The Lancet 28 August-3 September 2021 398(10302):759-771
Subject
Language
ISSN
0140-6736